A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: determined (252), resolute (3)

MyelomaVCD(IV28)Bortezomib(IV)CyclophosphamideDexamethasone28dayVer1

Description
Chemotherapy Protocol MULTIPLE MYELOMA VCD (IV-28) - BORTEZOMIB (IV)-CYCLOPHOSPHAMIDE-DEXAMETHASONE (28 day)
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaVCDIV28BortezomibIVCyclophosphamideDexamethasone28dayVer1.pdf

Myeloma VCD (SC35) bortezomib (SC) cyclophosphamide dexamethasone 35 day

Description
Chemotherapy Protocol MULTIPLE MYELOMA VCD (SC-35) - BORTEZOMIB (SC)-CYCLOPHOSPHAMIDE-DEXAMETHASONE (35 day)
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Myeloma-VCD-SC35-bortezomib-SC-cyclophosphamide-dexamethasone-35-day.pdf

Myeloma VCD (IV35) bortezomib (IV) cyclophosphamide dexamethasone 35 day

Description
Chemotherapy Protocol MULTIPLE MYELOMA VCD (IV-35) - BORTEZOMIB (IV)-CYCLOPHOSPHAMIDE-DEXAMETHASONE (35 day)
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Myeloma-VCD-IV35-bortezomib-IV-cyclophosphamide-dexamethasone-35-day.pdf

Lenvatinib(60kg or greater)

Description
Chemotherapy Protocol HEPATOCELLULAR CANCER LENVATINIB (60kg or greater) Regimen • Hepatocellular – Lenvatini
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Lenvatinib-60kg-or-greater-Ver1.pdf

Lenvatinib(59kg or less)

Description
Chemotherapy Protocol HEPATOCELLULAR CANCER LENVATINIB (59kg or less) Regimen • Hepatocellular – Lenvatinib I
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Lenvatinib-59kg-or-less-.pdf

BEACON protocol v8.0 07Mar2023 signed

Description
A randomised phase IIb trial of BE AC v izumab added to Temozolomide O ± Irin tecan for children with N refractory
Url
/Media/UHS-website-2019/Docs/PaediatricOncology/beacon-protocol-v8.0-07mar2023-signed.pdf

Sunitinib v1.1

Description
Regimen Renal Cell - Sunitinib Indication Chemotherapy Protocol RENAL CELL SUNITINIB First line treatment of advanced or metastatic renal cell carcinoma WHO
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Sunitinib-v1.1.pdf

Ibrutinib (MCL) (560mg)

Description
Chemotherapy Protocol Mantle Cell Lymphoma Regimen Ibrutinib • MCL – Ibrutinib (560mg) Indication • Mantle Cell
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Ibrutinib-MCL-560mg.pdf

Sunitinib v1

Description
Chemotherapy Protocol SARCOMA Gastro-Intestinal Stromal Tumour (GIST) Regimen Sunitinib GIST-Sunitinib Indication Sunitinib is recommended as a possible treatment for
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Sunitinib-v1.pdf

Vinorelbine PO (day 1, 8, 15) Ver 1.2

Description
Chemotherapy Protocol BREAST CANCER VINORELBINE Oral (Day 1, 8, 15) Regimen Breast Cancer – Vinorelbine Oral (day 1, 8, 15)
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Vinorelbine-PO-day-1-8-15-Ver-1.2.pdf
131 to 140 of 496
Previous … 12 13 14 15 16 … Next